Package Leaflet: Information for the Patient
Etoricoxib Genthon 30 mg film-coated tablets EFG
Etoricoxib Genthon 60 mg film-coated tablets EFG
Etoricoxib Genthon 90 mg film-coated tablets EFG
Etoricoxib Genthon 120 mg film-coated tablets EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack:
What is osteoarthritis?
Osteoarthritis is a disease of the joints. It leads to the breakdown of cartilage, the tissue that cushions the ends of the bones. This causes swelling (inflammation), pain, tenderness, stiffness, and disability.
What is rheumatoid arthritis?
Rheumatoid arthritis is a long-term inflammatory disease of the joints. It causes pain, stiffness, swelling, and progressive loss of movement in the affected joints. It also causes inflammation in other areas of the body.
What is gout?
Gout is a disease characterized by sudden, recurring attacks of very painful and inflamed joints. It is caused by deposits of mineral crystals in the joint.
What is ankylosing spondylitis?
Ankylosing spondylitis is an inflammatory disease of the spine and large joints.
Do not take Etoricoxib:
Etoricoxib may slightly increase your risk of heart attack and stroke, and this is why it should not be used in those patients who have already had heart problems or stroke.
If you think you are at risk of these conditions (for example, if you have high blood pressure, diabetes, high cholesterol, or are a smoker), or if you have had kidney or liver disease, your doctor will need to prescribe Etoricoxib with caution and will need to check for possible side effects.
Warnings and precautions
Consult your doctor or pharmacist before taking Etoricoxib if:
If you are not sure if any of the above applies to you, talk to your doctor before taking this medicineto check if etoricoxib is suitable for you.
Etoricoxib works just as well in older and younger adult patients. If you are over 65 years of age, your doctor will want to keep a closer check on you. No dose adjustment is necessary for patients over 65 years of age.
Children and adolescents
Do not give this medicine to children and adolescents under 16 years of age.
Taking Etoricoxib with other medicines
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines, including those obtained without a prescription.
In particular, if you are taking any of the following medicines, your doctor may want to check that your medicines are working properly once you start taking Etoricoxib:
Etoricoxib can be taken with low dosesof aspirin. If you are currently taking low doses of aspirin to prevent heart attacks or stroke, do not stop taking aspirin until you talk to your doctor.
do not take high dosesof aspirin or other anti-inflammatory medicines while taking etoricoxib.
Taking Etoricoxib with food and drink
The onset of action of Etoricoxib may be faster if taken without food.
Pregnancy, breast-feeding and fertility
Pregnancy
Etoricoxib tablets should not be taken during pregnancy. Do not take the tablets if you are pregnant, think you may be pregnant, or plan to become pregnant. If you become pregnant, stop taking the tablets and consult your doctor. Consult your doctor if you have any doubts or need more information.
Breast-feeding
It is not known if etoricoxib is excreted in human milk. If you are breast-feeding or plan to breast-feed, consult your doctor before taking Etoricoxib. If you are using Etoricoxib, do not breast-feed.
Fertility
Etoricoxib is not recommended for use in women who are trying to become pregnant.
Driving and using machines
In some patients taking Etoricoxib, dizziness and somnolence have been reported.
Do not drive if you experience dizziness or somnolence.
Do not use tools or machines if you experience dizziness or somnolence.
Etoricoxib Genthon tablets contain lactose
Etoricoxib Genthon contains lactose. If your doctor has told you that you have an intolerance to some sugars, consult with your doctor before taking this medicine.
This medicine contains less than 23 mg of sodium (1 mmol) per tablet; this is essentially “sodium-free”.
Follow exactly the instructions of administration of this medicine given to you by your doctor. In case of doubt, consult your doctor or pharmacist again.
Do not take more than the recommended dose for your condition. Your doctor will want to discuss your treatment from time to time. It is important that you use the lowest dose that controls your pain and you should not take Etoricoxib for longer than necessary. This is because the risk of heart attacks and strokes might increase after prolonged treatment, especially with high doses.
There are different doses available for this medicine, and depending on your disease, your doctor will prescribe the tablet with the dose that is suitable for you.
The recommended dose is:
Osteoarthritis
The recommended dose is 30 mg once daily, increased to a maximum of 60 mg once daily if needed.
Rheumatoid arthritis
The recommended dose is 60 mg once daily, increased to a maximum of 90 mg once daily if needed.
Ankylosing spondylitis
The recommended dose is 60 mg once daily, increased to a maximum of 90 mg once daily if needed.
Acute pain conditions
Etoricoxib should only be used for the period of acute pain.
Gout
The recommended dose is 120 mg once daily, which should only be used during the acute painful period, limited to a maximum of 8 days of treatment.
Postoperative dental pain
The recommended dose is 90 mg once daily, limited to a maximum of 3 days of treatment.
Patients with liver problems
Use in children and adolescents
Children or adolescents under 16 years of age should not take Etoricoxib tablets.
Patients over 65 years of age
No dose adjustment is necessary for patients over 65 years of age. As with other medicines, caution should be exercised in elderly patients.
Method of administration
This medicine is administered orally. Take the tablets once daily. Etoricoxib can be taken with or without food.
If you take more Etoricoxib than you should
Never take more tablets than your doctor recommends. If you take too many Etoricoxib tablets, seek medical attention immediately.
In case of overdose or accidental ingestion, you can also contact the Toxicological Information Service, Phone 91 562 04 20, indicating the medicine and the amount taken. It is recommended to bring the packaging and the leaflet of the medicine to the healthcare professional.
If you forget to take Etoricoxib
It is important that you take this medicine as your doctor has told you. If you forget a dose, just continue with your normal schedule. Do not take a double dose to make up for forgotten doses.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If you develop any of these signs, stop taking this medicine and talk to your doctor immediately:
The following side effects may occur during treatment with Etoricoxib:
Very common(may affect more than 1 in 10 people):
Common(may affect up to 1 in 10 people):
Uncommon(may affect up to 1 in 100 people):
Rare(may affect up to 1 in 1,000 people):
Reporting of side effects:If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date that appears on the box, after CAD. The expiration date is the last day of the month indicated.
This medicine does not require special storage conditions.
Medicines should not be thrown away via wastewater or household waste. Deposit the packaging and medicines you no longer need at the SIGRE Point of the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This way, you will help protect the environment.
Composition of Etoricoxib Genthon
Each 30 mg film-coated tablet contains 30 mg of etoricoxib.
Each 60 mg film-coated tablet contains 60 mg of etoricoxib.
Each 90 mg film-coated tablet contains 90 mg of etoricoxib.
Each 120 mg film-coated tablet contains 120 mg of etoricoxib.
Tablet core: microcrystalline cellulose (E460), magnesium stearate (E572), sodium croscarmellose (E468), hydrogenated calcium phosphate (E341)
Tablet coating: lactose monohydrate, hypromellose (E464), titanium dioxide (E171), triacetin (E1518).
Appearance of the Product and Package Contents
Etoricoxib Genthon tablets are available in four doses:
30 mg film-coated tablets: white, round, biconvex (approximately 6 mm) engraved with "E9OX" on one side and "30" on the other.
60 mg film-coated tablets: white, round, biconvex (approximately 8 mm) engraved with "E9OX" on one side and "60" on the other.
90 mg film-coated tablets: white, round, biconvex (approximately 9 mm) engraved with "E9OX" on one side and "90" on the other.
120 mg film-coated tablets: white, round, biconvex (approximately 10 mm) engraved with "E9OX" on one side and "120" on the other.
Package sizes of 2, 5, 7, 10, 14, 20, 28, 30, 49, 50, 84, 98, 100 tablets or multi-packs containing 98 (2 packs of 49 tablets) in blisters. Packages of 5 x 1, 50 x 1, 100 x 1 tablets in single-dose blisters.
Only some package sizes may be marketed.
Marketing Authorization Holder
Genthon BV
Microweg 22
6522 GC Nijmegen
Netherlands
Synthon Hispania S.L.
Polígono Las Salinas C/ Castelló 1
08830 Sant Boi de Llobregat
Spain
or
Synthon s.r.o. Blansko,
Brnenska 32/c.p.597
678 01 Blansko,
Czech Republic
This medicine is authorized in the member states of the European Economic Area under the following names:
Netherlands: Evetore 30/60/90/120 mg, tablets
Spain: Etoricoxib Genthon 30/60/90/120 mg film-coated tablets EFG
Denmark: Etorilin
Sweden: Coxolin 30/60/90/120 mg
Luxembourg: Evetore 30/60/90/120 mg
Date of the last revision of this prospectus: April 2021
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es